CD4 and breast carcinoma: Indeed, previous studies showed that activation of the leptin/ObR axis can result in a chronic inflammatory status (35, 66), a well-known risk factor for breast cancer, with leptin being involved in CD4+ T-regulatory cells differentiation due to ObR overexpression on lymphocyte plasm membrane (67).